Inspire Medical Systems, Inc.

Equities

INSP

US4577301090

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
214.8 USD +0.60% Intraday chart for Inspire Medical Systems, Inc. +10.02% +5.58%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Morgan Stanley Initiates Inspire Medical Systems at Overweight Rating With $250 Price Target MT
Transcript : Inspire Medical Systems, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 10:30 AM
UBS Adjusts Inspire Medical Systems Price Target to $265 From $220, Maintains Buy Rating MT
Mizuho Adjusts Price Target on Inspire Medical Systems to $250 From $225, Maintains Buy Rating MT
Inspire Medical Systems Q4 Net Income, Revenue Rise; Reaffirms 2024 Revenue Outlook MT
Transcript : Inspire Medical Systems, Inc., Q4 2023 Earnings Call, Feb 06, 2024
Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Reports Q4 Revenue $192.5M, vs. Street Est of $191.2M MT
Inspire Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Inspire Medical Systems, Inc. Reaffirms Revenue Guidance for the Full Year 2024 CI
Inspire Medical Systems, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Inspire Medical Systems Names CEO Timothy P. Herbert as Board Chair MT
Inspire Medical Systems, Inc. Announces Board Retirements CI
Inspire Medical Systems, Inc. Announces Jerry C. Griffin, M.D. from Its Board of Directors, Effective on May 2, 2024 CI
Jefferies Initiates Inspire Medical Systems With Buy Rating, Price Target is $245 MT
Transcript : Inspire Medical Systems, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 07:30 AM
Inspire Medical Systems Reports Preliminary Q4, Full Year 2023 Revenue; Issues 2024 Revenue Guidance MT
Inspire Medical Systems, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024 CI
Stifel Downgrades Inspire Medical Systems to Hold From Buy, Price Target is $210 MT
Inspire Medical Systems, Inc. Announces Appointment of Myriam J. Curet as Independent Director CI
Truist Securities Raises Price Target on Inspire Medical Systems to $260 From $240, Maintains Buy Rating MT
North American Morning Briefing : Dow Set For New -2- DJ
Wells Fargo Downgrades Inspire Medical Systems to Equalweight From Overweight, Cuts Price Target to $187 From $245 MT
Transcript : Inspire Medical Systems, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 02:00 PM
Transcript : Inspire Medical Systems, Inc. Presents at The Stifel 2023 Annual Healthcare Conference, Nov-15-2023 09:45 AM
Truist Adjusts Price Target on Inspire Medical Systems to $240 From $260, Maintains Buy Rating MT
Chart Inspire Medical Systems, Inc.
More charts
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
214.8 USD
Average target price
250.9 USD
Spread / Average Target
+16.83%
Consensus
  1. Stock
  2. Equities
  3. Stock Inspire Medical Systems, Inc. - Nyse
  4. News Inspire Medical Systems, Inc.
  5. Earnings Flash (INSP) INSPIRE MEDICAL SYSTEMS Posts Q1 Revenue $69.4M, vs. Street Est of $64.2M